Want to join the conversation?
For 2015, on a comparable and currency-neutral basis, $CCE expects diluted EPS to grow at the upper end of the range of 6-8% and sales growth is expected to be flat to slightly negative. Operating income is expected to grow slightly positive in 2015.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?